REVIEW PAPER
Advances in diagnosis and treatment of reactive arthritis
Online publication date: 2011-09-27
Reumatologia 2011;49(5):354-360
KEYWORDS
ABSTRACT
Reactive arthritis (ReA) is one of the seronegative spondyloarthropathies. ReA is an autoimmune arthritis, frequently preceded by a bacterial infection of the gastrointestinal or genitourinary tract. In 65-85% of patients suffering from ReA, HLA-B27 antigen is present. ReA is a disease with diverse clinical manifestations of the peripheral joints, spine, skin, eyes, digestive and other systems. A variety of symptoms means that patients, especially at the initial stage of the disease, are treated by specialists of different fields of medicine. The clinical picture of ReA is similar irrespective of the preceding infection type, but the therapy depends on the type of bacteria triggering the infection. Chlamydia infection may be persistent and treatment of Chlamydia-induced ReA is based on antibiotics. In other cases, the use of antibiotics is controversial. The course of ReA can be acute and often self-limiting. In some patients, a chronic arthritis develops. Early diagnosis of ReA and its effective treatment may prevent the development of chronic disease and lead to curing the disease completely.
REFERENCES (45)
2.
Allison DJ. Christopher Columbus: the first case of Reiter’s disease in the old world? Lancet 1980; 2: 1309. .
3.
Sharp JT. Reiter’s syndrome. In: Arthritis and allied conditions. Hollander JH, Mc Carthy DJ (eds.). Lea and Febiger, Philadelphia 1979; 1223-1229. .
4.
Sydenham T. The works of Thomas Sydenham MD. Translated by Latham RG. Sydenham Society II. London 1848. 257-259. .
6.
Yvan AU. Observation sur une metastase de gonorrhee. Ann Soc Med Prat de Montpellier 1806; 119-125. .
7.
Brodie BC. Pathological and surgical observations on diseases of the joints. Longman, London 1818; 54. .
8.
Launois MPE. Arthropaties recidivantes amythrophie generalize trobles trophiques multiples. D’origine blennofthalmique. Bull Mem Soc Med Hop 1897; 14: 93-104. .
9.
Cooper A. On gonorrheal Rheumatism. On gonorrheal ophthalmia. Lancet 1824; 2: 273-274. .
10.
Flessinger N, Leroy E. Contribution a l’etude d’une epidemie de dydenterie dans la Somme. Bull Mem Soc Med Hop 1916; 40: 2030-2069. .
11.
Reiter H. Uber eine bisher unerkannte spirochaten infection. Dtsch Med Wochenschr 1916; 42: 1535-1536. .
12.
Bauer W, Engelman EP. Syndrome of unknown etiology characterized by urethritis, conjunctivitis and arthritis (so-called Reiter’s disease). Trans Assoc Am Phys 1942; 57: 307-313. .
13.
Wallace DJ, Weisman J. The physician Hans Reiter as prisoner of war in Nuremberg: a contextual review of his interrogations (1945-1947). Semin Arthritis Rheum 2003; 32: 208-230. .
14.
Keyan Y, Rimar D. Reactive Arthritis – The Appropriate Name. IMAJ 2008; 10: 256-258. .
15.
Willkens RF, Arnett FC, Bitter T, et al. Reiter’s syndrome: evaluation of preliminary criteria for definite diseases. Arthritis Rheum 1981; 24: 844-849. .
16.
Kingsley GH, Sieper J. Third International Workshop on Reactive Arthritis. 23-26 September 1995. Berlin, Germany. Ann Rheum Dis 1996; 55: 564-584. .
17.
Sieper J, Braun J, Kingsley GH. Report on the Fourth International workshop on reactive arthritis. Arthritis Rheum 2000; 43: 720-734. .
18.
Colmegna I, Cuchacivich R, Espinoza LR. HLA B27 associated reactive arthritis: pathogenetic and clinical considerations. Clin Microbiol Rev 2004; 17: 348-369. 19. Toivanen P, Toivanen. A Two forms of reactive arthritis. Ann Rheum Dis 1999; 58: 737-741. .
19.
Mielants H, Veys EM, Joos R, et al. HLA antigens in seronegative spondylarthropathies. Reactive arthritis and arthritis in ankylosing spondylitis: relation to gut inflammation. J Rheumatol 1987; 14: 466-471. .
20.
Shimamoto Y, Sugiyama H, Hirohata S. Reiter’s syndrome associated with HLA-B51. Intern Med 2000; 39: 182-184. .
21.
Singh R, Aggarwal A, Misra R. Th1/Th17 cytokine profiles in patients with reactive arthritis/undifferentiated spondyloarthropathy. J Rheumatol 2007; 34: 2285-2290. .
22.
Dean D, Kandel RP, Adhikari HK, et al. Multiple chlamydiaceae species in trachoma: implications for disease pathogenesis and control. PLoS Medicine 2008; 5: 57-68. .
23.
Gérard HC, Whittum-Hudson JA, Carter JD, et al. The pathogenic role of Chlamydia in spondyloarthritis. Curr Opin Rheumatol 2010; 22: 363-367. .
24.
Rabenau H, Berger A, Doerr HW, et al. Testing for Chlamydia trachomatis in urine. Lancet 1997; 349: 1024-1025. .
25.
Bas S, Vischer TL. Chlamydia trachomatis antibody detection and diagnosis of reactive arthritis. Br J Rheumatol 1998; 37: 1054-1959. .
26.
Wilkinson NZ, Kingsley GH, Sieper J, et al. Lack of correlation between the detection of Chlamydia trachomatis DNA in synovial fluid from patients with a range of rheumatic diseases and the presence of an antichlamydial immune response. Arthritis Rheum 1998; 41: 845-854. .
27.
Fendler C, Laitko S, Sorensen G, et al. Frequency of triggering bacteria in patients with reactive arthritis and undifferentiated oligoarthritis and the relative importance of the tests used for diagnosis. Ann Rheum Dis 2000; 60: 337-343. .
28.
Granfors K, Merilahti-Palo R, Luukkainen R, et al. Persistence of Yersinia antigens in peripheral blood cells from patients with Yersinia enterocilitica O:3 infection with or without reactive arthritis. Arthritis Rheum 1998; 41: 855-862. .
29.
Locht H, Krogfeld KA. Comparison of rheumatological and gastrointenstinal symptoms after infection with Campylobacter jejuni/coli and enteroxigenic Escherichia coli. Ann Rheum Dis 2002; 61: 448-452. .
30.
Sieper J, Rudwaleit M, Braun J, et al. Diagnosing reactive arthritis. Arthritis Rheum 2002; 46: 319-327. .
31.
D’Agostino MA, Aegerter P, Bechara K, et al. How to diagnose spondyloarthritis early/ Accuracy of peripheral enthesitis detection by power Doppler utrasonography. Ann Rheum Dis 2011; 70: 1433-1440. .
32.
Weber U, Maksymowych WP. Sensitivity and specificity of magnetic resonance for axial spondyloarthritis. Am J Med Sci 2011; 341: 272-277. .
33.
Matthias B, Braun J, Matthias T, et al. CT-guided intraarticular corticosteroid injection into sacroiliac joints in patients with spondyloarthropathy: indication and follow-up with contrast-enhanced MRI. J Comp Assisted Tomography 1996; 20: 512-521. .
34.
Clegg DO, Reda DJ, Abdellatif M. Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestation of the seronegative spondyloarthropathies. Arthritis Rheum 1999; 42: 2325-2329. .
35.
Ritchelin CT, Daikh BE. Recent advances in the treatment of seronegative spondyloarthropathies. Curr Rheumatol Rep 2001; 3: 299-403. .
36.
Abdelmoula LC, Yahia CB, Testouri N, et al. Treatment of reactive arthritis with infliximab. Tunis Med 2008; 86: 1095-1097. .
37.
Schafranski MD. Infliximab for reactive arthritis secondary to Chlamydia trachomatis infection. Rheumatol Int 2009; 30: 679-680. .
38.
Flagg SD, Meador R, Hsia E, et al. Decreased pain and synovial inflammation after etanercept therapy in patients with reactive and undifferentiated arthritis: an open-label trial. Arthritis Rheum 2005; 53: 613-617. .
39.
Bardin T, Enel C, Cornelis F, et al. Antibiotic treatment of veneral disease and Reiter’s syndrome in a Greenland population. Arthritis Rheum 1992; 35: 190-194. .
40.
Lauhio A, Leirisalo-Repo M, Lahdevirta J, et al. Double-blind, placebo controlled study of free month treatment with limecycline in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis Rheum 1991; 34: 6-14. .
41.
Dreses-Werringloer U, Padubrin I, Zeidler H, et al. Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro. Antimicrob Agents Chemother 2001; 45: 3001-3008. .
42.
Carter JD, Valeriano J, Vasey FB. A prospective, randomized 9-month comparison of doxycycline and rifampin in undifferentiated spondyloarthritis – with special reference to Chlamydia-induced arthritis. J Rheumatol 2004; 31: 1973-1980. .
43.
Bin XX, Wolf C, Schaffner T, et al. Effect of Azithromycin plus Rifampin versus Amoxicillin Alone on Eradycation and Inflammation in the Chronic Course of Chlamydia pneumoniae pneumonitis in Mice. Antimicrob Agents Chemother 2000; 44: 1761-1764. .
44.
Sieper J, Fendler S, Laitko S, et al. No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis. Arthritis Rheum 1999; 42: 1386-1396. .
45.
Yli-Kerttula T, Luukkainen R, Yli-Kerttula U. Effect of a three month course of ciprofloxacin on the late prognosis of reactive arthritis. Ann Rheum Dis 2003; 62: 880-884.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Share
RELATED ARTICLE
| eISSN: | 2084-9834 |
| ISSN: | 0034-6233 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
